Home > Analytics > SHREE GANESH BIOTECH (INDIA)

SHREE GANESH BIOTECH (INDIA)
Intrinsic Value | Fundamental Analysis

BOM : 539470     NSE :     
LT :  
    Long Term Analysis
Fundamentals : Bad
Valuation : Good [Stock is Cheap]
Debt : Low
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward
Pledged Shares : None or < 25%
Dec 02,2022
Price(EOD): ₹ 1.61
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
Agriculture
MCap: ₹ 64.17 Cr
Value of ₹ 1 Lac invested in SHREE GANESH BIOTECH (INDIA)
on Dec 04,2017 (price: ₹ 11.25)

₹ 1 L

₹ 0.14 L

1W : -5.9% 1M : -5.3% 1Y : -77%
COMMUNITY POLL
for SHREE GANESH BIOTECH (INDIA)
Please provide your vote to see the results
SHREE GANESH BIOTECH (INDIA) is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
Industry Peers & Returns1W1M1Y
SHREE GANESH BIOTECH (INDIA) -5.9% -5.3% -77%
BOMBAY BURMAH TRADING CORPORATION 9.5% 14.5% 0.9%
VENKYS (INDIA) -0.4% -5.1% -26.1%
KAVERI SEED COMPANY 1.2% 7.9% 2.6%
NATH BIOGENES (INDIA) 2% 0.9% -35.7%
HARRISONS MALAYALAM 5.2% 6.8% -3.6%
JK AGRI GENETICS -0.2% 2% -22.5%
BOMBAY SUPER HYBRID SEEDS -0.6% 32% 398.8%
MANGALAM GLOBAL ENTERPRISE 2.6% -3.2% 59.9%

FUNDAMENTAL ANALYSIS OF SHREE GANESH BIOTECH (INDIA)

 
Fundamentals Score
[ Q(TTM): Sep2022, Y: Mar2022
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]


VALUATION OF SHREE GANESH BIOTECH (INDIA)

 
Valuation Score
[As on : Dec 02,2022 ]

Ratio Standalone
P/E
P/B
P/S
15.19
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 4.23 Cr
[Latest Qtr - Sep2022 - Standalone Results ]

1.06
P/B Calculated based on Book Value of Rs 60.32 Cr
[Latest Year - Mar2022 - Standalone Results ]

0.79
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 0.00 Cr
[Latest Qtr - Sep2022 - Standalone Results ]

Financial Ratios →

Insights 💡 SHREE GANESH BIOTECH (INDIA) is one of the potential top 16% undervalued companies ! Discover More →

FAIR VALUE OF SHREE GANESH BIOTECH (INDIA)

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
92%
-87%
-97%

Insights 💡 You can learn about various Valuation techniques to calculate Intrinsic Value
with our bestselling video course Value Investing - The Ultimate Guide
Take Me There →

SHARE PRICE MOMENTUM OF SHREE GANESH BIOTECH (INDIA)



SHREE GANESH BIOTECH (INDIA) vs SENSEX


Insights 💡 You can learn about Basics of Stock Marketing Investing
with our bestselling video course Stock Marketing Investing Simplified
Take Me There →

DEBT OF SHREE GANESH BIOTECH (INDIA)

Year Debt/Equity ratio
Standalone Consolidated
2022
2021
2020
Avg_3yrs
0
0
0
-
-
-
-
-
[Last Annual Data : Mar2022]
Financial Ratios →

PLEDGED PROMOTER SHARES OF SHREE GANESH BIOTECH (INDIA)

Pledged Promoter Shares
0 %
As on : Sep2022

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad
Shareholding Pattern →

QTRLY RESULTS OF SHREE GANESH BIOTECH (INDIA)

Standalone Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
6.26%
14.92%
16.28%
16.28%
21.14%
44.28%
45.63%
45.63%
QtrlyTrend
8
Latest Qtr: Sep2022
Quarterly Result Analysis →

Insights 💡 SHREE GANESH BIOTECH (INDIA) is one of the top 42% companies with good quarterly result uptrend ! Discover More →

SHREE GANESH BIOTECH (INDIA) related INDICES

No BSE index found!
No NSE index found

You may also like the below Video Courses


FAQ about SHREE GANESH BIOTECH (INDIA)


Is SHREE GANESH BIOTECH (INDIA) good for long term investment?

As on Dec 02,2022, the Fundamentals of SHREE GANESH BIOTECH (INDIA) look Poor and hence it may not be good for long term investment ! See Financial Performance of SHREE GANESH BIOTECH (INDIA) . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is SHREE GANESH BIOTECH (INDIA) UnderValued or OverValued?

As on Dec 02,2022, SHREE GANESH BIOTECH (INDIA) is Under Valued based on the estimates of intrinsic value and hence may be a good buying opportunity according to Share Valuation at this time!

What is the Intrinsic Value of SHREE GANESH BIOTECH (INDIA) ?

As on Dec 02,2022, the Intrinsic Value of SHREE GANESH BIOTECH (INDIA) is Rs. 12.16 estimated based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 0.84
Fair Value [Median EV / Sales Model] : Rs. 12.16
Fair Value [Median Price / Sales Model] : Rs. 53.63
Estimated Median Fair Value of SHREE GANESH BIOTECH (INDIA) : Rs. 12.16

The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.

Is SHREE GANESH BIOTECH (INDIA) trading at a Premium or Discount?

As on Dec 02,2022, SHREE GANESH BIOTECH (INDIA) is trading at a Discount of -87% based on the estimates of Median Intrinsic Value!

SEBI Research Analyst
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].